Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 21, 2025 • 8:00 PM ET

Date/Time Source News Release
05/13/2025 07:00 AM EDT GlobeNewswire Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights
05/07/2025 04:00 PM EDT GlobeNewswire Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference
05/06/2025 04:00 PM EDT GlobeNewswire Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
04/02/2025 07:00 AM EDT GlobeNewswire Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
04/01/2025 07:00 AM EDT GlobeNewswire Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
03/27/2025 07:00 AM EDT GlobeNewswire Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2024 and Business Highlights
03/26/2025 08:00 AM EDT GlobeNewswire Acumen Pharmaceuticals Completes Enrollment of ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease
03/20/2025 04:00 PM EDT GlobeNewswire Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
03/19/2025 08:00 AM EDT GlobeNewswire Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers
03/18/2025 08:48 AM EDT GlobeNewswire Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's
Page

Additional News

As of June 21, 2025 • 8:00 PM ET

Date/Time Source News Release
05/13/2025 10:12 AM EDT SeekingAlpha Acumen targets ALTITUDE-AD Phase 2 topline results in late 2026 while advancing subcutaneous Sabirnetug development
05/13/2025 10:11 AM EDT SeekingAlpha Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript
05/13/2025 07:04 AM EDT SeekingAlpha Acumen Pharmaceuticals GAAP EPS of -$0.48 beats by $0.06
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Acumen Pharmaceuticals Inc.
05/12/2025 06:48 PM EDT KlickAnalytics ABOS - Historical Price Movements Surrounding Earnings
05/12/2025 06:43 PM EDT KlickAnalytics ABOS - Historical Earnings Price Analysis
03/27/2025 10:05 AM EDT SeekingAlpha Acumen Pharmaceuticals outlines ALTITUDE AD Phase 2 plans and late 2026 data timeline
03/27/2025 10:05 AM EDT SeekingAlpha Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript
03/27/2025 07:19 AM EDT SeekingAlpha Acumen Pharmaceuticals reports FY results
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.